Forecasts data is unavailable for this security.
Consensus recommendation
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Bicara Therapeutics Inc have a median target of 41.50, with a high estimate of 47.00 and a low estimate of 36.00. The median estimate represents a 88.64% increase from the last price of 22.00.
High | 113.6% | 47.00 |
Med | 88.6% | 41.50 |
Low | 63.6% | 36.00 |
Earnings history & estimates in USD
More ▼